newsfilter
← Latest News
GlobeNewswire·

Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update

Appointed Pharma Industry Veteran Brendan O’Grady as Chief Executive Officer Company on Track to Advance Clinical Programs to Key Second Half 2026 Milestones TEL AVIV, Israel, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nasus